Contact Info
Stuart Chalk, Ph.D.
Department of Chemistry
University of North Florida
Phone: 1-904-620-1938
Fax: 1-904-620-3535
Email: schalk@unf.edu
Website: @unf
Ondansetron
- IUPAC Name: 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
- Molecular Formula: C18H19N3O
- CAS Registry Number: 116002-70-1
- InChI: InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3
- InChI Key: FELGMEQIXOGIFQ-UHFFFAOYSA-N
Citations 1
"Continuous-flow Injection Atomic Absorption Spectrometric Method For The Determination Of Ondansetron"
Anal. Chim. Acta
1995 Volume 300, Issue 1-3 Pages 143-148
L. Lahuerta Zamoraa and J. Martínez Calatayudb,*
Abstract:
A solid-phase reactor was prepared from PbO2 entrapped by polymerization of unsaturated esters in a polyester resin. The powdered material of particle size 200-250 µm was introduced into a 1.5 mm i.d. PTFE tube and placed in a FIA continuous-flow manifold. An aqueous solution of ondansetron in H2SO4 medium was injected into a carrier stream of water and passed through the reactor at a flow rate of 5.4 ml/min. The released Pb(II) was monitored by AAS at 217 nm. The calibration graph was linear in the range 0.5-20 µg/ml of ondansetron at room temperature and, for a sample volume of 405 µL, the throughput was 338 samples/h. The RSD for 10 µg/ml of analyte at room temperature and 80°C were 2% (n = 29) and 1.8% (n = 35), respectively. The between-day reproducibility had a RSD of 2.1% and foreign compounds did not interfere. The method was applied to the analysis of tablets.
Pharmaceutical
Spectrophotometry
Solid phase reagent
Interferences